Abstract: The embodiments of the present disclosure relate to antigens of ?-coronaviruses, preparation methods and uses thereof. The amino acid sequence of the antigen of the ?-coronavirus includes an amino acid sequence arranged in a (A-B)-(A-B) pattern or an amino acid sequence arranged in a (A-B)-C-(A-B) pattern or an amino acid sequence arranged in a (A-B)-(A-B?) pattern or an amino acid sequence arranged in a (A-B)-C-(A-B?) pattern. The antigen of the ?-coronavirus has a single-chain dimer structure. A single-chain dirtier expressed according to examples of the present disclosure is stable in content and has excellent immunogenicity as an antigen of a ?-coronavirus, and a vaccine prepared by using the single-chain dimer as an antigen of a ?-coronavirus can elicit high-titer neutralizing antibodies in mice.

Abstract: Described herein is a blocked polyisocyanate crosslinking agent obtained from reactions of components including a). at least one polyisocyanate selected from the group consisting of aliphatic polyisocyanate, cycloaliphatic polyisocyanate and polyisocyanate-functional polymer and b). at least one beta-diketone. Also described herein is a method of preparing a blocked polyisocyanate crosslinking agent as well as coating compositions including the blocked polyisocyanate crosslinking agent.

Abstract: Described herein is a 2K clearcoat composition including, Component I including a). at least one resin having carboxylic acid groups with acid value of 50 to 400 mg KOH/g; b). at least one resin having hydroxyl functional groups with a hydroxyl value of 10 to 800 mg KOH/g; c). at least one catalyst; and d). at least one solvent, and Component II including e). at least one epoxy-functional alkoxysilane and/or its oligomer and/or its polymer; and f). at least one crosslinker reactive to hydroxyl groups. Also described herein are a substrate coated with the dried and cured 2K clearcoat composition and an automotive including the substrate.

Abstract: A control resource allocation method, an apparatus, an electronic device, and at least one non-transitory computer readable storage medium are provided. The method includes identifying resource usage status information for the first period, and determining control resource set (CORESET) time-frequency resources and uplink/downlink (UL/DL) control channel element (CCE) patterns for the first period, based on the resource usage status information.

Abstract: The embodiments of the present disclosure relate to antigens of ?-coronaviruses, preparation methods and uses thereof. The amino acid sequence of the antigen of the ?-coronavirus includes an amino acid sequence arranged in a (A-B)-(A-B) pattern or an amino acid sequence arranged in a (A-B)-C-(A-B) pattern or an amino acid sequence arranged in a (A-B)-(A-B?) pattern or an amino acid sequence arranged in a (A-B)-C-(A-B?) pattern. The antigen of the ?-coronavirus has a single-chain dimer structure. A single-chain dirtier expressed according to examples of the present disclosure is stable in content and has excellent immunogenicity as an antigen of a ?-coronavirus, and a vaccine prepared by using the single-chain dimer as an antigen of a ?-coronavirus can elicit high-titer neutralizing antibodies in mice.

Abstract: A resource processing method and apparatus. The method is achieved by a computer configured to execute the following steps: generating a resource allocation chart based on a resource allocation request; processing the resource allocation chart and generating an access entrance of the resource allocation chart; opening the access entrance to enable at least one third party resource supplier to respond to the resource allocation request via the access entrance. The method further comprises: when the resources are not available or not suitable for allocation, receiving a resource allocation chart, wherein the resource allocation chart is based on the resource allocation request; generating an access entrance of the resource allocation chart; opening the access entrance to at least one third party resource supplier; and receiving the allocated resources from the at least one third party resource supplier by responding to the resource allocation request through the access entrance.

Abstract: A surgical training system may include a model base having at least one channel therein and opening outwardly to a top surface. A model insert may be removably coupled to the top surface of the model base. The model insert may include tissue for surgical training and a plurality of connectors coupled to the tissue and slidably received within the at least one channel.

Abstract: A resource processing method and apparatus. The method is achieved by a computer configured to execute the following steps: generating a resource allocation chart based on a resource allocation request; processing the resource allocation chart and generating an access entrance of the resource allocation chart; opening the access entrance to enable at least one third party resource supplier to respond to the resource allocation request via the access entrance. The method further comprises: when the resources are not available or not suitable for allocation, receiving a resource allocation chart, wherein the resource allocation chart is based on the resource allocation request; generating an access entrance of the resource allocation chart; opening the access entrance to at least one third party resource supplier; and receiving the allocated resources from the at least one third party resource supplier by responding to the resource allocation request through the access entrance.

Abstract: A method and apparatus for simulating a medical procedure to be performed on a patient. Patient-specific data that is specific to the patient on whom the medical procedure is to be performed is received. A generic model is modified using the patient-specific data to generate a hybrid simulation model that is customized to the patient. A simulation of the medical procedure is performed using the hybrid simulation model and dynamic simulation information corresponding to at least one of the medical procedure or the patient. The simulation is customized to both the patient and the medical procedure.

Abstract: Strengthening resins and processes for making and using same. In some embodiments, a resin mixture can include a solvent and a strengthening resin. The strengthening resin can include one or more hydrophobic monomers incorporated therein. The strengthening resin can have a chemical formula of (I). The chemical formula (I) can include: where each R2 can be derived from a hydrophobic monomer.

Abstract: A method for controlling data transmission, device, and storage medium are provided. The method for controlling data transmission is applied to a first device and the method includes that a request for data transmission is sent; a main transmission path that fed back by a second device based on the request is received, here, the main transmission path is generated by connecting M sink nodes between the first device and the second device and M is an integer greater than 1; and the data transmission with the second device is performed according to the main transmission path.

Abstract: Disclosed herein is a stator plate for a rotary bed PSA apparatus that has an exhaust slot that has first and second sections for receiving blowdown and purge exhaust gas streams, the sections being separated by a flow restriction that restricts but does not full prevent gas flow between the sections, or that has separate exhaust slots for separately receiving the blowdown and purge exhaust gas streams. Also disclosed is pressure swing adsorption (PSA) apparatus including such a stator plate, and a rotary bed PSA process using such an apparatus.

Abstract: Disclosed are an intelligent traditional Chinese medicine diagnosis method, system and traditional Chinese medicine system, the method comprising: a server side obtaining, from distributed client clusters, inspection training data, auscultation-olfaction diagnosis training data, interrogation training data and palpation training data of a patient; the server side training, by using the inspection training data, the auscultation-olfaction diagnosis training data, the interrogation training data and the palpation training data, a model to be trained established on the basis of a deep neural network algorithm to obtain a trained model; and the server side using the trained model to perform diagnosis with respect to disease data of the patient to obtain a diagnostic result of the disease data.

Abstract: Method are provided for treating a wellbore or subterranean hydrocarbon-bearing formation to increase hydrocarbon recovery from the formation by in-depth mobility control and/or fluid diversion conformance by introducing a water soluble acrylamide polymer and a non-metallic organic crosslinking agent, or a crosslinkable acrylamide polymer, into an injection fluid entering the wellbore or the formation.

Abstract: This invention is to be applied to a person's ear. The biophotonic mask instrument consists of an ear covering component, an ear attachment component, and multiple light emitting units. The biophotonic mask instrument is connected to an external intelligent electronic device with an application to control the operation of the light emitting units. The attachment component is to be clipped onto the body of the ear with the ear covering component connected to it. The multiple light emitting units are arranged to be 0.8 mm to 1.2 mm apart or 0.65 mm to 1.5 mm apart. The light emitting units are in a net design and their wave lengths are between 400 nm to 1000 nm. The biophotonic mask instrument is wirelessly connected to the intelligence device.

Abstract: The present invention belongs to the field of pharmaceutical chemistry, and relates to a substituted pyrrolopyrimidine CDK inhibitor, in particular to a compound as shown in formula I or a pharmaceutically acceptable salt or solvate thereof, as well as a preparation method thereof and a pharmaceutical composition thereof. The present invention also relates to the use of the compound and the pharmaceutical composition thereof in the preparation of a drug for treating diseases associated with CDK inhibition. The compound according to the present invention has a marked inhibitory effect on CDK, excellent drug absorption and significantly superior oral absorption effect.

Abstract: Disclosed herein is a stator plate for a rotary bed PSA apparatus that has an exhaust slot that has first and second sections for receiving blowdown and purge exhaust gas streams, the sections being separated by a flow restriction that restricts but does not full prevent gas flow between the sections, or that has separate exhaust slots for separately receiving the blowdown and purge exhaust gas streams. Also disclosed is pressure swing adsorption (PSA) apparatus including such a stator plate, and a rotary bed PSA process using such an apparatus.

Abstract: A method of operating a surgical control system comprises displaying an image of a surgical environment, from a field of view of an imaging instrument, on a display system. The display system is configured for mounting to a head of a user. The method also includes detecting an imaging control input from the user and responsive to the detection of the imaging control input, enabling an imaging control mode of the surgical control system. The method also includes detecting a movement of the head of the user. While the surgical control system is in the imaging control mode and responsive to the user's head movement, an image of the surgical environment from a changed field of view of the imaging instrument is displayed. The changed field of view corresponds to the detected movement of the user's head.

Abstract: A display device is provided. The display device includes an organic light emitting diode display panel, a blue light brightness enhancement film and a polarizing film. The blue light brightness enhancement film is disposed on the organic light emitting diode display panel. The blue light brightness enhancement film includes a cholesteric liquid crystal layer and a quarter-wave phase retardation film, and the quarter-wave phase retardation film is disposed on the cholesteric liquid crystal layer. The polarizing film is disposed on the blue light brightness enhancement film.